Cargando…
Quantitative Assessment of Response to Long‐Term Treatment with Intravenous Immunoglobulin in Patients with Stiff Person Syndrome
BACKGROUND: Stiff person syndrome (SPS) is an autoimmune condition involving antibodies against several components of the inhibitory synapse in the spinal cord, with glutamic acid decarboxylase antibodies being the predominant immune marker. SPS affects approximately 1 patient per million population...
Autores principales: | Bose, Smriti, Thompson, Joseph P., Sadalage, Girija, Karim, Abid, Jacob, Saiju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354084/ https://www.ncbi.nlm.nih.gov/pubmed/34401404 http://dx.doi.org/10.1002/mdc3.13261 |
Ejemplares similares
-
Current Proposed Mechanisms of Action of Intravenous Immunoglobulins in Inflammatory Neuropathies
por: Jacob, Saiju, et al.
Publicado: (2009) -
Susac syndrome: neurological update (clinical features, long-term observational follow-up and management of sixteen patients)
por: Bose, Smriti, et al.
Publicado: (2023) -
Use of subcutaneous immunoglobulin in stiff person syndrome: Case series
por: Aljarallah, Salman, et al.
Publicado: (2021) -
Severe Periodontal Disease Associated with Long-Term Treatment with Intravenous Immunoglobulin
por: Corrêa, Jôice Dias, et al.
Publicado: (2014) -
Recalcitrant, delayed pressure urticaria treated with long-term intravenous immunoglobulin
por: Soliman, Yssra S., et al.
Publicado: (2020)